莫沙必利、乳果糖联合双歧杆菌治疗老年2型糖尿病功能性便秘128例

Effect of mosapride,lactulose and bifidobacterium on treatment of 128 elderly type 2 diabetic patients with functional constipation

  • 摘要: 目的:观察分析128例老年2型糖尿病功能性便秘患者消化内科治疗方法及临床疗效。方法选取128例老年2型糖尿病功能性便秘患者为研究对象,采用数字法随机将患者分为两组,其中观察组68例给予莫沙必利、乳果糖联合双歧杆菌治疗,对照组60例给予单纯莫沙必利治疗,观察比较两组患者临床疗效、症状改善、4~12周后复发率及不良反应情况。结果观察组总有效率为91.2%,高于对照组70.0%,治疗后观察组排便频率、排便困难程度、腹胀腹痛、排便不尽三项症状改善均优于对照组,观察组患者8~12周复发率为10.3%、16.2%,低于对照组23.3%、43.3%,在腹胀、腹泻、腹痛、腹部不适及总不良反应发生率均低于对照组(P <0.05)。结论消化内科采用莫沙必利、乳果糖联合双歧杆菌三联疗法治疗老年2型糖尿病功能性便秘临床疗效显著,能够有效的改善患者排便困难等临床症状,减少停药后复发率,不良反应较少,值得临床推广应用。

     

    Abstract: Objective To explore the effect of mosapride,lactulose and bifidobacterium on treatment of 128 elderly type 2 diabetic patients with functional constipation.Methods 128 elderly type 2 diabetic patients with functional constipation were randomly divided into observation group (n =68,treated with mosapride,lactulose and bifidobacterium)and the control group (n =60, treated with mosapride).Clinical curative effect after 4~12 weeks,recurrence rate and incidence rate of adverse reactions were compared between two groups.Results In the observation group, the total effective rate was 91.2%,which was higher than 70% in the control group.Defecation frequency,difficulty degree of defecation,abdominal distention,endless defecate in the observation group were better than the control group.The recurrence rate in the observation group was signifi-cantly lower than the control group.Incidence rate of adverse reactions such as abdominal disten-sion,diarrhea,abdominal discomfort in the observation group was significantly lower than the con-trol group (P <0.05).Conclusion Application of mosapride,lactulose and bifidobacterium triple therapy in treatment of elderly diabetic patients with functional constipation can effectively improve the clinical symptoms,reduce the relapse rate and avoid incidence of adverse reactions,so it is wor-thy of clinical application.

     

/

返回文章
返回